Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |